Torti Frank
CIK 0001647805
President and Vant ChairDirector
Filings
12
Latest Apr 9, 2026
Issuers covered
3
Showing
12 of 12
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | -1.0% | -1.5% | +1.4% | -2.9% |
| 90 days | 3 | 0% | -12.8% | -13.7% | -6.9% | -17.8% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Torti Frank has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IMVT | Immunovant, Inc. | 5 | Apr 9, 2026 |
| ROIV | Roivant Sciences Ltd. | 4 | Apr 2, 2026 |
| ABUS | Arbutus Biopharma Corp | 3 | May 24, 2024 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|